193 related articles for article (PubMed ID: 28130841)
1. DMBT1 expression in biliary carcinogenesis with correlation of clinicopathological data.
Goeppert B; Roessler S; Becker N; Zucknick M; Vogel MN; Warth A; Pathil-Warth A; Mehrabi A; Schirmacher P; Mollenhauer J; Renner M
Histopathology; 2017 Jun; 70(7):1064-1071. PubMed ID: 28130841
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort.
Jansson H; Cornillet M; Björkström NK; Sturesson C; Sparrelid E
Eur J Surg Oncol; 2020 May; 46(5):804-810. PubMed ID: 31848078
[TBL] [Abstract][Full Text] [Related]
3. Sox9 expression in carcinogenesis and its clinical significance in intrahepatic cholangiocarcinoma.
Matsushima H; Kuroki T; Kitasato A; Adachi T; Tanaka T; Hirabaru M; Hirayama T; Kuroshima N; Hidaka M; Soyama A; Takatsuki M; Kinoshita N; Sano K; Nishida N; Eguchi S
Dig Liver Dis; 2015 Dec; 47(12):1067-75. PubMed ID: 26341967
[TBL] [Abstract][Full Text] [Related]
4. The expression of matrix metalloproteinases in intrahepatic cholangiocarcinoma, hilar (Klatskin tumor), middle and distal extrahepatic cholangiocarcinoma, gallbladder cancer, and ampullary carcinoma: role of matrix metalloproteinases in tumor progression and prognosis.
Kirimlioğlu H; Türkmen I; Başsüllü N; Dirican A; Karadağ N; Kirimlioğlu V
Turk J Gastroenterol; 2009 Mar; 20(1):41-7. PubMed ID: 19330734
[TBL] [Abstract][Full Text] [Related]
5. Gamma-synuclein is a novel prognostic marker that promotes tumor cell migration in biliary tract carcinoma.
Takemura Y; Ojima H; Oshima G; Shinoda M; Hasegawa Y; Kitago M; Yagi H; Abe Y; Hori S; Fujii-Nishimura Y; Kubota N; Masuda Y; Hibi T; Sakamoto M; Kitagawa Y
Cancer Med; 2021 Aug; 10(16):5599-5613. PubMed ID: 34245137
[TBL] [Abstract][Full Text] [Related]
6. miRNA profiling of biliary intraepithelial neoplasia reveals stepwise tumorigenesis in distal cholangiocarcinoma via the miR-451a/ATF2 axis.
Loeffler MA; Hu J; Kirchner M; Wei X; Xiao Y; Albrecht T; De La Torre C; Sticht C; Banales JM; Vogel MN; Pathil-Warth A; Mehrabi A; Hoffmann K; Rupp C; Köhler B; Springfeld C; Schirmacher P; Ji J; Roessler S; Goeppert B
J Pathol; 2020 Nov; 252(3):239-251. PubMed ID: 32710569
[TBL] [Abstract][Full Text] [Related]
7. Biliary intraepithelial neoplasia (BilIN) is frequently found in surgical margins of biliary tract cancer resection specimens but has no clinical implications.
Matthaei H; Lingohr P; Strässer A; Dietrich D; Rostamzadeh B; Glees S; Roering M; Möhring P; Scheerbaum M; Stoffels B; Kalff JC; Schäfer N; Kristiansen G
Virchows Arch; 2015 Feb; 466(2):133-41. PubMed ID: 25425476
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer.
Goeppert B; Frauenschuh L; Zucknick M; Stenzinger A; Andrulis M; Klauschen F; Joehrens K; Warth A; Renner M; Mehrabi A; Hafezi M; Thelen A; Schirmacher P; Weichert W
Br J Cancer; 2013 Nov; 109(10):2665-74. PubMed ID: 24136146
[TBL] [Abstract][Full Text] [Related]
9. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma.
Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y
Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030
[TBL] [Abstract][Full Text] [Related]
10. Predictive and prognostic values of ERCC1 and XRCC1 in biliary tract cancers.
Mian M; McNamara MG; Doherty M; Hedley D; Knox JJ; Serra S
J Clin Pathol; 2016 Aug; 69(8):695-701. PubMed ID: 26763622
[TBL] [Abstract][Full Text] [Related]
11. Serum CYFRA 21-1 in Biliary Tract Cancers: A Reliable Biomarker for Gallbladder Carcinoma and Intrahepatic Cholangiocarcinoma.
Huang L; Chen W; Liang P; Hu W; Zhang K; Shen S; Chen J; Zhang Z; Chen B; Han Y; Meng F; DeMorrow S; Yin X; Lai J; Liang L
Dig Dis Sci; 2015 May; 60(5):1273-83. PubMed ID: 25487191
[TBL] [Abstract][Full Text] [Related]
12. Oncogenic KRAS-expressing organoids with biliary epithelial stem cell properties give rise to biliary tract cancer in mice.
Kasuga A; Semba T; Sato R; Nobusue H; Sugihara E; Takaishi H; Kanai T; Saya H; Arima Y
Cancer Sci; 2021 May; 112(5):1822-1838. PubMed ID: 33068050
[TBL] [Abstract][Full Text] [Related]
13. Dyskerin expression in human fetal, adult and neoplastic intrahepatic bile ducts: correlations with cholangiocarcinoma aggressiveness.
Vasuri F; Rocchi L; Degiovanni A; Giunchi F; Brandi G; Treré D; Montanaro L; D'Errico-Grigioni A
Histopathology; 2015 Jan; 66(2):244-51. PubMed ID: 25367684
[TBL] [Abstract][Full Text] [Related]
14. Different expression patterns of mucin core proteins and cytokeratins during intrahepatic cholangiocarcinogenesis from biliary intraepithelial neoplasia and intraductal papillary neoplasm of the bile duct--an immunohistochemical study of 110 cases of hepatolithiasis.
Zen Y; Sasaki M; Fujii T; Chen TC; Chen MF; Yeh TS; Jan YY; Huang SF; Nimura Y; Nakanuma Y
J Hepatol; 2006 Feb; 44(2):350-8. PubMed ID: 16360234
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection.
Utsumi M; Kitada K; Tokunaga N; Yoshida Y; Narusaka T; Hamano R; Miyasou H; Tsunemitsu Y; Otsuka S; Inagaki M
Anticancer Res; 2021 Apr; 41(4):2147-2155. PubMed ID: 33813426
[TBL] [Abstract][Full Text] [Related]
16. Spatiotemporal analysis of tumour-infiltrating immune cells in biliary carcinogenesis.
Charbel A; Tavernar L; Albrecht T; Brinkmann F; Verheij J; Roos E; Vogel MN; Köhler B; Springfeld C; Brobeil A; Schirmacher P; Singer S; Mehrabi A; Roessler S; Goeppert B
Br J Cancer; 2022 Nov; 127(9):1603-1614. PubMed ID: 36068277
[TBL] [Abstract][Full Text] [Related]
17. Decreased expression of TFPI-2 correlated with increased expression of CD133 in cholangiocarcinoma.
Chu X; Zhao P; Lv Y; Liu L
Int J Clin Exp Pathol; 2015; 8(1):328-36. PubMed ID: 25755719
[TBL] [Abstract][Full Text] [Related]
18. Peribiliary Glands as the Cellular Origin of Biliary Tract Cancer.
Nakagawa H; Hayata Y; Yamada T; Kawamura S; Suzuki N; Koike K
Int J Mol Sci; 2018 Jun; 19(6):. PubMed ID: 29895797
[TBL] [Abstract][Full Text] [Related]
19. Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract.
Riener MO; Vogetseder A; Pestalozzi BC; Clavien PA; Probst-Hensch N; Kristiansen G; Jochum W
Hum Pathol; 2010 Nov; 41(11):1558-65. PubMed ID: 20621328
[TBL] [Abstract][Full Text] [Related]
20. Capecitabine plus cisplatin as first-line chemotherapy for advanced biliary tract cancer: a retrospective single-center study.
Woo SM; Lee WJ; Han SS; Park SJ; Kim TH; Koh YH; Kim HB; Hong EK; Park JW; Kim CM
Chemotherapy; 2012; 58(3):225-32. PubMed ID: 22831988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
